Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

Mcfarland L., Karakan T., Karataş A.

ECLINICALMEDICINE, cilt.41, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 41
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.eclinm.2021.101154
  • Dergi Adı: ECLINICALMEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: Probiotic, Irritable bowel syndrome, Gastrointestinal, Meta-analysis, Diarrhea, Constipation, LACTOBACILLUS-PLANTARUM 299V, RANDOMIZED CONTROLLED-TRIAL, PLACEBO-CONTROLLED TRIAL, CEREVISIAE CNCM I-3856, DOUBLE-BLIND, CLINICAL-TRIAL, FERMENTED MILK, SACCHAROMYCES-CEREVISIAE, IMPROVES SYMPTOMS, FECAL MICROBIOTA
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Consistent guidance for choosing an appropriate probiotic for the treatment of irritable bowel syndrome is lacking.